期刊文献+

bcr-abl和白介素-7共表达基因疫苗诱导小鼠免疫保护作用 被引量:1

Immune protective mechanisms of gene vaccines with co-expressing bcr-abl fusion gene fragment and mouse IL-7 gene
原文传递
导出
摘要 目的探讨小鼠白介素-7(IL-7)基因对bcr-abl融合基因疫苗诱导机体免疫应答的影响。方法采用pVbcr-abl/mIL-7质粒免疫BALB/c小鼠,检测小鼠血清中bcr-abl特异性抗体水平。以转染bcr-abl融合基因片段的SF2/0细胞为靶细胞,用LDH释放实验检测免疫小鼠脾细胞特异性细胞毒活性。结果pVbcr-abl/mIL-7质粒能诱导小鼠产生血清特异性抗bcr-abl抗体,pVbcr-abl/mIL-7免疫组的血清特异性抗体滴度高于pVbcr-abl免疫组,脾细胞杀伤SP2/0/bcr-abl靶细胞的细胞毒活性明显增强。结论共表达bcr-abl和mIL-7的基因疫苗能在小鼠体内诱导较高的特异性体液免疫和细胞免疫水平,为慢性粒细胞白血病基因疫苗的临床前实验研究提供了依据。 Objective To investigate the influence of raiL-7 on the immune response induced by vaccine of bcr-abl fusion gene fragment in mouse. Methods BALB/c mice were immunized by i. m. injection of pVbcr-abl/mIL-7 and pVbcr-abl, respectively. The specific antibody to p210^bcl-abl protein was assayed by ELISA, The CTL activity of spleen cells from the immunized mice was assessed with LDH release test. Results The pVbcr-abl/mIL-7 and pVbcr-abl-immunized BALB/c mice elicited higher specific antibodies to p210^bcr-abl protein. The specific antibody level of former group was higher than that in latter group, but the difference was statistically not significant. The spleen cells from the immunized mice showed more effective CTL activity than that from control group. The cytotoxic activity of spleen CTLs induced by pVbcr-abl/mIL-7 immunized mice exceeded that of pVbcr-ab-immunized mice. Conclusion The mIL-7 may influence the growth and differentiation of T cells, promote some T cells migrating into tumor tissue and up-regulate the specific cellular immune response. The results of this study provided an useful experimental basis for preclinical research on gene vaccine for chronic myeloid leukemia.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2007年第2期93-95,共3页 Chinese Journal of Oncology
基金 江苏省自然科学基金资助项目(BK2006706、BK2004404)
关键词 IL-7基因 BCR-ABL基因 基因疫苗 保护作用 IL-7 gene bcr-abl gene Gene vaccine
  • 相关文献

参考文献12

  • 1王春红,孙秉中,袁跃传.bcr-abl融合基因抑制K562细胞凋亡的研究[J].中华肿瘤杂志,1998,20(5):340-341. 被引量:8
  • 2姜扬文,钱莉,刘伟,龚卫娟,万兵,管俊,季明春.稳定表达bcr-abl融合基因片段的鼠SP2/0细胞系的建立[J].中国实验血液学杂志,2005,13(4):601-604. 被引量:4
  • 3钱莉,季明春,姜扬文,徐向明,龚卫娟,李厚达.慢性髓性白血病bcr-abl融合基因的克隆与表达[J].扬州大学学报(农业与生命科学版),2003,24(2):21-23. 被引量:3
  • 4Weidmann E, Brieger J, Jahn B, et al. Lactate dehydragenaserelease assay: a reliable nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lyric activity against blasts from acute myelocytic leukemia. Ann Hematol, 1995, 70: 153-158.
  • 5Schwartz J, Pinilla-Ibarz J, Yuan RR, et al. Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia. Semin Hematol, 2003, 40 : 87-96.
  • 6Giralt S, Hester J, Huh Y, et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 1995, 86: 4337-4343.
  • 7ten Bosch G J, Toomvliet AC, Friede T, et al. Recoginifion of poptides corresponding to the joining region of p210bcr-abl protein by human T cells. Leukemia, 1995, 9: 1344-1348.
  • 8Buzyn A, Ostankovitch M, Zerbib A, et al. Peptides derived from the whole sequence of BCR-ABL bind to several class Ⅰ molecules allowing specific induction of human cytotoxic T lymphecytes. Eur J Immunol, 1997, 27 : 2066-2072.
  • 9Melchionda F, Fry TJ, Mackall CL. Harnessing the immune modulatory effects of IL-7 for immunotherapy. Clin Appl ImmunolRev, 2003, 4: 71-89.
  • 10Bertagnolli M, Herrmann S. IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity. Immunol, 1990, 145: 1706-1712.

二级参考文献18

  • 1Regelson W. Have we found the "definitive cancer biomarker"? the diagnostic and therapeutic implications of human chorionic gonadotropinbeta expression as a key to malignancy. Cancer, 1995, 76:1299-1301.
  • 2Acevedo HF, Tong JY,Hartsock Pal. Human chorionic gonadotrophinbeta subunit gene expression in cultured human fetal and cancer of different types and origins. Cancer, 1995, 76:1467-1475.
  • 3Acevedo HF, Hartsock R J, Maroon JC. Detection of membrane -associated human chorionic gonadotrophin and its subunits on human cultured cancer cells of the nervours system. Cancer Detect Prev, 1997,21 : 295-303.
  • 4Triozzi PI, Stevens VC. Human chorionic gonadotrophin as a target for cancer vaccines. Oncol Rep, 1999, 6: 7-17.
  • 5Triozzi PL, Stevens VC, Aldrich W, et al. Effects of a β-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer. Clin Cancer Res, 1997,3:2355-2362.
  • 6Moulton HM, Yoshiham PH, Mason DH, et al. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res, 2002, 8: 2044-2051.
  • 7Geissler M, Wands G, Gesien A, et al. Genetic immunization with the free human chorionic gonadotrophin β subunit elicits cytotic T lymphocyte responses and protects against tumor formation in mice. Lab Invest,1997, 76:859-871.
  • 8Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune responses. Nature, 1992, 356:152-154.
  • 9Acevedo HF, Hartsock Pd. Metastatic phenotype correhtes with high expression of membrane-associated complete β-human chorionic gonadotrophin in vivo. Cancer, 1996, 78: 2388-2399.
  • 10Kalantarov G, Acevedo HF. Demonstration of dose dependent cytotoxic activity in cancer cells by specific human chorionic gonadotrophin monaclonal antibodies. Cancer, 1998, 83:783-787.

共引文献15

同被引文献9

  • 1Cheuk AT,Mufti GJ,Guinn BA.Role of 4-1BB:4-1BB li-gand in cancer immunotherapy.Cancer Gene Ther,2004,11:215-226.
  • 2Watts TH.Tnf/Tnfr family members in costimulation of T cell responses.Annu Rev Immunol,2005,23:23-68.
  • 3Dawicki W,Watts TH.Expression and function of 4-1BB during CD4 versus CD8 T cell response in vivo.Eur J Immunol,2004,34:743-751.
  • 4Galsky MD,Eisenberger M,Moore-Cooper S,et al.Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer.J Clin Oncol,2008,26:2147-2154.
  • 5Sloots A,Mastini C,Rohrbach F,et al.DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.Clin Cancer Res,2008,14:6933-6943.
  • 6Jemal A,Siegel R,Ward E,et al.Cancer Statistics,2008.CA Cancer J Clin,2008,58:71-96.
  • 7Kaufman HL,Wang W,Manola J,et al.Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897):a trial of the Eastern Cooperative Oncology Group.J Clin Oncol,2004,22:2122-2132.
  • 8Wilcox RA,Flies DB,Zhu G,et al.Provision of antigen and CD137 signaling breaks immunological ignorance,promoting regression of poorly immunogenic tumors.J Clin Invest,2002,109:651-659.
  • 9Lin CT,Tsai YC,He L,et al.DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.Immunol Lett,2007,114:86-93.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部